-
-
Daniel Halpern
Chief Executive Officer & DirectorDaniel Halpern brings over 30 years of international experience building, growing, financing and investing in global healthcare and technology companies. Dan provides strategy, investment and operations support for emerging growth companies.
He currently serves as President of Healthcare Investors, LLC, a business development and investment company, Advisory Board Member of Breast-Med, Inc., and board member and co-founder of Phyzhon Health, fka Vascular Imaging Corporation, an early-stage interventional medical device company.
Dan is actively engaged in developing new technology-based companies. Portfolio companies are primarily involved in applications of medical imaging and image-guided therapeutics.
Previously, Dan served as President and co-founder of Sunlight Research, LLC , a patent claims analysis and intellectual property market research firm, and he served in senior management roles with Financing for Science International, an equipment leasing company acquired by Finova Group Inc. (NYSE: FNV); Elscint, Inc. (NYSE: ELT), a medical diagnostic imaging equipment manufacturer, whose medical imaging businesses were acquired by GE Medical and Philips/Marconi; and Elron Electronic Industries Ltd. (TASE: ELRN), an international industrial holding company headquartered in Israel, where he served as U.S. General Manager.
Dan holds an MBA degree from New York University's Stern School of Business and a B.A. degree from the University of Michigan.Ivan Ma
Chief Product OfficerIvan Ma brings over 15 year of experience in the medical device industry in various leadership and design positions spanning a wide range of medical devices; from single use to complex surgical hardware. Most recently he was a manager of robotic systems at Verb Surgical, at Verily (an Alphabet company) and Ethicon (a Johnson and Johnson company) joint venture, where led various teams toward critical program milestones starting from the company’s inception in 2016. Prior to that, Ivan had leading and engineering roles in the companies with a broad range of technologies such as: intracardiac pacemaker, therapeutic hypothermia, deep brain stimulation, cryogenic tissue ablation, a cell phone enabled otoscope, and a white blood cell imaging system. Ivan has specialized in bringing early phase projects through development in preparation for FDA submission and human use. Ivan holds a B.S. in mechanical engineering from Boston University.
-
Theodore P. Abraham
M.D., Crystalline Medical Founder & Chairman of the BoardDr. Abraham is currently The Meyer Friedman Distinguished Professor of Medicine at University of California in San Francisco where he is Clinical Chief of Cardiology and Director of Echocardiography. Until July 2017 he was Professor of Medicine, and Radiology and Radiologic Service and Associate Dean for Research at Johns Hopkins University. He was also Director of Echocardiography and Director Johns Hopkins HCM Center of Excellence. He is a board certified clinical cardiologist with advanced training in ultrasound.
He has been involved in ultrasound research funded by the NIH and industry for 20 years and has peer-reviewed publications in almost all major cardiac ultrasound technologies, including transthoracic and transesophageal echocardiography, three-dimensional echocardiography, contrast echocardiography, tissue Doppler and strain echocardiography, and small animal imaging. Dr. Abraham is an active clinical echocardiographer and started echo-guided pericardiocentesis at Johns Hopkins.Gary Gershony
M.D., DirectorSerial MedTech Entrepreneur and Early-Stage Investor, Dr. Gershony was the Founder of Vascular Solutions, which had a successful IPO in 2000, and for which he served as Chief Medical Officer and a member of the Board of Directors from 1996-2002.
Dr. Gershony was the principal inventor of the Duett™ Vascular Sealing Device manufactured by Vascular Solutions. He was also the Co-Founder and Chief Medical Officer of AngioScore, a medical device company devoted to developing unique angioplasty scoring balloon catheters to address a variety of important clinical needs during coronary and peripheral interventional procedures.
He was a member of the senior management team from 2003 until AngioScore’s successful acquisition in 2014. Dr. Gershony is the author of 11 issued medical device patents. He has been a member of the scientific advisory board or a consultant to numerous medical device companies and venture capitalists in the Bay Area and elsewhere.Robert Rothstein
M.D., DirectorDr Rothstein is an Emergency Physician by training with years of clinical and administrative experience. He was Chair of the Department of Emergency Medicine at Harbor/UCLA Medical Center establishing one of the foremost Emergency Medicine training programs in the US. He served as CEO of Bethesda Emergency Associates.
Subsequently, he was appointed Vice President of Medical Affairs at Johns Hopkins Suburban Hospital. He has authored numerous peer reviewed publications and textbooks. He served on the board of directors for the American Board of Emergency Medicine.
He has been involved in multiple medtech companies. He is Chair of the Clinical Advisory Board for UV Angel, Cofounder and Member of Board of Directors for AirX medical, Member Board of Directors for Civic Suds and served as Chief Medical Officer for VidaShield.
He was involved in the formation, and served as a medical advisor, for Medically Home, Inc. that received a large round of funding from the Mayo Clinic and Kaiser Permanente in May 2021.Daniel Halpern
Chief Executive Officer & DirectorDaniel Halpern brings over 30 years of international experience building, growing, financing and investing in global healthcare and technology companies. Dan provides strategy, investment and operations support for emerging growth companies.
He currently serves as President of Healthcare Investors, LLC, a business development and investment company, Advisory Board Member of Breast-Med, Inc., and board member and co-founder of Phyzhon Health, fka Vascular Imaging Corporation, an early-stage interventional medical device company.
Dan is actively engaged in developing new technology-based companies. Portfolio companies are primarily involved in applications of medical imaging and image-guided therapeutics.
Previously, Dan served as President and co-founder of Sunlight Research, LLC , a patent claims analysis and intellectual property market research firm, and he served in senior management roles with Financing for Science International, an equipment leasing company acquired by Finova Group Inc. (NYSE: FNV); Elscint, Inc. (NYSE: ELT), a medical diagnostic imaging equipment manufacturer, whose medical imaging businesses were acquired by GE Medical and Philips/Marconi; and Elron Electronic Industries Ltd. (TASE: ELRN), an international industrial holding company headquartered in Israel, where he served as U.S. General Manager.
Dan holds an MBA degree from New York University's Stern School of Business and a B.A. degree from the University of Michigan.
-